Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001193125-26-452089·Latigo Biotherapeutics, Inc.
Schedule 13G ownership disclosure
LATIGO BIOTHERAPEUTICS
Common stock, par value $0.0001 per share · CUSIP: 517954103
Event date: 2026-09-03
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- AI Biotechnology LLC
Shares: 3,193,565 · Class: 4.8%
- Access Industries Holdings LLC
Shares: 3,193,565 · Class: 4.8%
- Access Industries Management, LLC
Shares: 3,193,565 · Class: 4.8%
- Len Blavatnik
Shares: 3,193,565 · Class: 4.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-26-452089
- Form type
- SCHEDULE 13G/A
- Filer
- Latigo Biotherapeutics, Inc.
- CIK
- CIK 2056611
- Filed
- Nov 06, 2026
- Reporting period
- Sep 03, 2026
- Description
- Schedule 13G beneficial ownership